Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001047469-18-000577
Filing Date
2018-02-02
Accepted
2018-02-02 16:14:57
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3/A a2234436zs-3a.htm S-3/A 156604
2 EX-4.5 a2234436zex-4_5.htm EX-4.5 43197
3 EX-5.1 a2234436zex-5_1.htm EX-5.1 15441
4 EX-23.1 a2234436zex-23_1.htm EX-23.1 3116
5 G33281KQI001.GIF g33281kqi001.gif GRAPHIC 2031
6 G33281KQI002.GIF g33281kqi002.gif GRAPHIC 4566
7 G622400.JPG g622400.jpg GRAPHIC 30586
  Complete submission text file 0001047469-18-000577.txt   271096
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-222634 | Film No.: 18570819
SIC: 2834 Pharmaceutical Preparations